Skip to main content
. 2017 Sep 15;8(46):80941–80955. doi: 10.18632/oncotarget.20895

Table 2. GM reductions in patients with PSP compared to healthy controls.

Cluster Anatomical label Peak MNI coordinate (x, y, z) No. of voxels SDM-Z value SDM-p value Egger's test (p value)
A Left inferior frontal gyrus/insula/superior temporal gyrus/precentral gyrus (premotor cortex)/putamen/OFC (BAs 47, 13, 44, 22, 6, 45, and 9) -48, 18, 0 5063 -4.80 ∼0 0.56
B Right/Left thalamus/midbrain/caudate nucleus 4, -14, 6 3916 -4.70 ∼0 0.29
C Right/Left ACC/(pre-) SMA/superior medial frontal cortex/medial OFC (BAs 32, 24, 8, 9, 6,11, and 10) -4, 12, 44 3457 -3.32 0.000067 0.27
D Right inferior frontal gyrus/insula/superior temporal gyrus/putamen/precentral gyrus (premotor cortex) (BAs 44, 13, 47, 22, 6, 45, and 9) 54, 16, 16 3186 -4.27 0.027743R254 0.78
E Left anterior cerebellum (lobule III/IV/V) -14, -44, -24 108 -2.74 0.0014 0.83

Key: GM, Gray Matter; PSP, Progressive Supranuclear Palsy; MNI, Montreal Neurological Institute; No., Number; SDM, Seed-based d Mapping; BA, Brodmann Area; OFC, Orbitofrontal Cortex; ACC, Anterior Cingulate Cortex; SMA, Supplementary Motor Area.